Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Barbora Ravčuková is active.

Publication


Featured researches published by Barbora Ravčuková.


Journal of Sex & Marital Therapy | 2007

Links among paroxetine-induced sexual dysfunctions, gender, and CYP2D6 activity.

Alexandra Žourková; Eva Češková; Eva McCaskey Hadašová; Barbora Ravčuková

The aim of the study was to compare the distribution of therapeutic efficacy and sexual dysfunction during maintenance paroxetine treatment in 17 males and 38 females genotyped and phenotyped to determine their CYP2D6 metabolic status. Clinical results were monitored on scales Clinical Global Impression-Severity of Illness Scale (CGIS) and Arizona Sexual Experience Scale (ASEX). The phenotype procedure showed 7 males and 12 females with extensive metabolic status (EM) and 10 males and 26 females with poor metabolic status (PM). No variation in therapeutic efficacy between male and female subjects classified as PM and those marked as EM was found. A significantly higher rate of sexual dysfunction (p = 0.01) was recorded among females with a PM phenotype.


Archive | 2008

Genetický polymorfismus CYP2D6 u pacientů léčených Paroxetinema modelování mutantních forem CYP2D6

Eva Flodrová; Jan Juřica; Antonín Pavelka; Petr Jaša; Barbora Ravčuková; Jana Házová; Eva Chovancová; Jiří Damborský; Renata Gaillyová; Alexandra Žourková


Psychiatrie | 2007

Mentální bulimie a léčba paroxetinem, sledování aktivity CYP2D6

Ivana Palčíková; Alexandra Žourková; Eva McCaskey Hadašová; Daria Valentová; Barbora Ravčuková


Archive | 2007

Mentální bulimie a léčba paroxetinem-sledování aktivity CYP2D6(předběžné výsledky) poster

Ivana Palčíková; Alexandra Žourková; Eva McCaskey Hadašová; Barbora Ravčuková


European Psychiatry | 2007

Mental bulimia and paroxetine treatment - monitoring CYP2D6 activity (preliminary results)

I. Palcíková; A. Zourková; D. Valentová; Eva McCaskey Hadašová; Barbora Ravčuková


Psychiatrie, časopis pro moderní psychiatrii | 2006

Léčba antidepresivy: volba dle aktivity CYP2D6 a pohlaví

Alexandra Žourková; Eva McCaskey Hadašová; Lucie Pilařová; Miroslav Robeš; Barbora Ravčuková


Archive | 2006

Clinical impact of CYP2D6 activity in long-term paroxetinetreatment

Alexandra Žourková; Eva McCaskey Hadašová; Lucie Pulkrábková; Barbora Ravčuková; Tomáš Kašpárek


Archive | 2006

Mentální bulimie, léčba paroxetinem a ovlivnění aktivity CYP2D6(předběžné výsledky)

Ivana Palčíková; Alexandra Žourková; Daria Valentová; Eva McCaskey Hadašová; Barbora Ravčuková


Archive | 2006

Bulimia nervosa, paroxetine treatment and the influence ofactivity CYP2D6 (pre-results)

Ivana Palčíková; Alexandra Žourková; Daria Valentová; Eva McCaskey Hadašová; Barbora Ravčuková


Homeostasis | 2006

Molecular genetic detection of alleles of the CYP2D6 gene inpatinets with depression or anxiety disorders

Barbora Ravčuková; Eva McCaskey Hadašová; Jana Házová; Alexandra Žourková; Renata Gaillyová

Collaboration


Dive into the Barbora Ravčuková's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alexandra Žourková

Central European Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Ivana Palčíková

Central European Institute of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Martin Falk

Academy of Sciences of the Czech Republic

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge